from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2971/-

LFCtreatmentdescriptionclass of inhibitor

0.713

Amikacinug/mL Amikacintranslation

1.153

Cap5-10ug/mL Capreomycintranslation

1.159

Rox10-50 ug/mL Roxithromycintranslation

1.119

SM2-5 ug/mL Streptomycintranslation

1.112

Tet5-10 ug/mL Tetracyclinetranslation

-0.256

Rif0.2-5ug/mL Rifampicintranscription

-0.175

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.253

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.450

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.380

CPZ10-50 ug/mL Chlorpromazinerespiration

0.057

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.217

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.395

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.627

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.333

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.137

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.018

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.443

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.256

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.012

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.986

KCN5-20 ug/mL Potassium cyaniderespiration

0.116

NaN30.2-2 mM Sodium aziderespiration

0.821

Nigericin50 uM Nigericinrespiration

-0.631

TRC10-150 ug/mL Triclosanrespiration

-1.013

TRZ10-25 ug/mL Thioridazinerespiration

0.187

Valinomycin0.5-10 uM Valinomycinrespiration

0.448

ZnSO42 mM ZnSO4respiration

1.030

menadione6-10 ug/mL Menadionerespiration

0.492

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.584

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.485

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.367

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.099

NRP_1Non-replicating persistence stage 1dosRassociated

0.366

Amp0.2mg/mL AmpicillincellWall

0.410

Cephalexin20-100 ug/mL CephalexincellWall

0.837

Cerulenin0.32-5 ug/mL CerulenincellWall

0.908

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.689

EMB10-20 ug/mL EthambutolcellWall

0.615

Eta12-40 ug/mL EthionamidecellWall

0.108

INH0.2-0.4 ug/mL IsoniazidcellWall

1.812

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.265

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.347

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.353

BZA0.12 mg/mL BenzamidearomaticAmides

-1.569

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.647

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.259

H2O24 mM hydrogen peroxideDNAdamaging

0.237

Levo10 ug/mL LevofloxacinDNAdamaging

0.065

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.266

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.675

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.175

UVUV-irradiationDNAdamaging

-0.296

ARP41-4 ug/mL Antitubercular compound ARP4?

0.842

Antimycin12.5-50 ug/mL Antimycin A?

0.953

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.761

PA_110-50 ug/mL Antitubercular compound PA-1?

0.815

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.426

PA8240.2-2 ug/mL PA-824?

0.386

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.019

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.989

Verapamil50 uM Verapamil?

1.182

mercaptoethanol2 mM 2-Mercaptoethanol?

0.502

methoxatin10-20 ug/mL Methoxatin?